Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Retained Earnings: 2018-2019

Historic Retained Earnings for DiaMedica Therapeutics (DMAC) over the last 1 years, with Sep 2019 value amounting to -$54.1 million.

  • DiaMedica Therapeutics' Retained Earnings was N/A to -$54.1 million in Q3 2019 from the same period last year, while for Sep 2019 it was -$54.1 million, marking a year-over-year change of. This contributed to the annual value of -$46.0 million for FY2018, which is N/A change from last year.
  • DiaMedica Therapeutics' Retained Earnings amounted to -$54.1 million in Q3 2019, which was down 4.74% from -$51.7 million recorded in Q2 2019.
  • In the past 5 years, DiaMedica Therapeutics' Retained Earnings registered a high of -$46.0 million during Q4 2018, and its lowest value of -$54.1 million during Q3 2019.
  • In the last 2 years, DiaMedica Therapeutics' Retained Earnings had a median value of -$50.5 million in 2019 and averaged -$50.3 million.